MaaT Pharma Announces Positive Second Safety Interim Analysis from DSMB for Phase 2b PHOEBUS Trial…
MaaT PharmaOctober 7, 2025
Musée de sciences biologiques Dr Mérieux Annual Conference - October 9, 2025
MaaT PharmaOctober 6, 2025
MaaT Pharma Publishes its Half Year 2025 Results and Provides a Business Update Positive results…
MaaT PharmaSeptember 17, 2025
